Skip to main content
Back to Deerfield

Deerfield's Biotechnology Portfolio

Browse 56 Biotechnology companies funded by Deerfield. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
56
Total Funding in Biotechnology
$4.3B

Biotechnology Portfolio Companies (56)

Export
BiotechnologyHealth CareMedicalNeuroscience

Innvervace develops regenerative therapy solutions for neurodegenerative disorders.

Philadelphia, United States
September 2022
$40.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device

Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.

Waltham, United States
September 2024
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

San Francisco, United States
July 2022
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical DeviceOncology

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Ann Arbor, United States
July 2021
$90.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.

Bethesda, United States
June 2023
$12.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyEmergency MedicineMedical

Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.

Palo Alto, United States
June 2023
$145.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsMedical

Advanced Medicine Partners is a biotechnology company that specializes in viral vector manufacturing for genes and cells.

Lake Forest, United States
June 2024
$32.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceuticalPrecision MedicineTherapeutics

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

San Francisco, United States
June 2024
$20.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Elutia is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.

Silver Spring, United States
June 2024
$13.3M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Abivax develops medicines that alter the body's natural immune system mechanisms.

Paris, France
May 2026
$45.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncology

Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases

New York, United States
May 2022
$400K
Pre-Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.

Cambridge, United States
May 2022
$50.0M
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Cambridge, United States
April 2022
$20.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Dublin, Ireland
April 2026
$117.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsManufacturingMedical Device

Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.

Carlsbad, United States
April 2022
$35.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Apertura Gene Therapy is a biotechnology company that treats debilitating diseases with limited options.

Newyork, United Kingdom
April 2022
$67.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$5.0M
Convertible Note

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

San Diego, United States
April 2026
$125.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth CareTherapeutics

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.

San Diego, United States
April 2026
$100.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalProduct Design

Hallux develops a new topical dosage form and route of administration for treating onychomycosis.

Laguna Hills, United States
April 2022
$9.4M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Aurion Biotechnologies is a clinical-stage biotech company.

Seattle, United States
April 2022
$120.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyDatabaseData ManagementData StorageInformation Technology

Atlas Data Storage is an information technology company focused on data storage solutions.

South San Francisco, United States
March 2026
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsProduct Research

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.

Lake Forest, United States
March 2022
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

San Diego, United States
March 2025
$20.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalWellness

MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.

Mississauga, Canada
March 2023
$16.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceOncologyTherapeutics

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Cambridge, United States
February 2026
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceutical

Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications.

Bozeman, United States
February 2022
$38.0M
Series A

Founder Contacts

41,000+ verified contacts

BioinformaticsBiotechnologyGenetics

Actio Biosciences is a research center that develops drugs for rare diseases.

San Diego, United States
June 2025
$66.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth CareHealth DiagnosticsMedicalPrecision Medicine

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

Menlo Park, United States
March 2025
$31.8M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth Diagnostics

Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.

San Diego, United States
December 2024
$25.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsHospitalPrecision Medicine

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

La Jolla, United States
April 2023
$24.0M
Series G

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Cambridge, United States
January 2026
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsHospitalMedicalmHealthWellness

LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing.

Atlanta, United States
January 2025
$165.0M
Series F

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

South San Francisco, United States
January 2023
$78.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareLife Science

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Cambridge, United States
January 2024
$100.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.

London, United Kingdom
December 2025
$26.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Appello Pharmaceuticals is a preclinical-stage company focused on CNS disorders.

Nashville, United States
January 2022
$13.5M
Series B

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife Science

Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.

New York, United States
December 2025
$70.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsMedicalTherapeutics

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

South San Francisco, United States
December 2021
$300.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsMedical

Ascend helps make and sell gene therapy treatments. We know a lot about how to create and share these special medicines.

Alachua, United States
November 2024
$130.6M
Undisclosed

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.

Cambridge, United States
November 2025
$500.0M
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife Science

Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.

New York, United States
October 2022
Series E

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

Lausanne, Switzerland
October 2025
$60.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Ness Ziona, Israel
December 2025
$3.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Saint-herblain, France
October 2025
$215.0M
Post Ipo Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyConsultingManufacturingTherapeutics

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

Potters Bar, United Kingdom
May 2023
$65.9M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine.

La Jolla, United States
May 2021
$130.5M
Convertible Note

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth Care

Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation.

Champaign, United States
December 2020
$25.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyMedical

Great Lakes Discoveries is a company set up by University of Michigan to boost drug commercialisation efforts.

New York, United States
May 2020
$130.0M
Undisclosed

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.

Redwood City, United States
August 2019
$80.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Chondrial Therapeutics is clinical-stage biotechnology that focuses on developing orphan drugs for mitochondrial diseases.

Bala Cynwyd, United States
May 2019
$25.8M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Stelexis Therapeutics is a company utilizes pre-cancerous stem cells to discover and develop transformative therapies.

New York, United States
January 2019
$43.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalMedical Device

Pinnacle Hill is the drug spinout company.

England, Germany
October 2018
$65.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyTherapeutics

Lakeside Discovery accelerates the translation of transformative biomedical technologies.

New York, United States
June 2018
$65.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth Care

Concert Genetics provides physicians with the information they need to find the right test for their patients.

Franklin, United States
January 2018
Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncology

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

Waltham, United States
June 2016
$409.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

Explore Deerfield's Full Portfolio

View all companies funded by Deerfield across every industry and funding stage.

View Full Deerfield Portfolio